0001162194-21-000006.txt : 20210223 0001162194-21-000006.hdr.sgml : 20210223 20210223215708 ACCESSION NUMBER: 0001162194-21-000006 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210220 FILED AS OF DATE: 20210223 DATE AS OF CHANGE: 20210223 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Linthwaite Stephen Christopher CENTRAL INDEX KEY: 0001680808 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-34180 FILM NUMBER: 21668327 MAIL ADDRESS: STREET 1: C/O FLUIDIGM CORPORATION STREET 2: 7000 SHORELINE COURT, SUITE 100 CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: FLUIDIGM CORP CENTRAL INDEX KEY: 0001162194 STANDARD INDUSTRIAL CLASSIFICATION: LABORATORY ANALYTICAL INSTRUMENTS [3826] IRS NUMBER: 770513190 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 7000 SHORELINE COURT STREET 2: SUITE 100 CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 BUSINESS PHONE: 6502666000 MAIL ADDRESS: STREET 1: 7000 SHORELINE COURT STREET 2: SUITE 100 CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 4 1 wf-form4_161413540879138.xml FORM 4 X0306 4 2021-02-20 0 0001162194 FLUIDIGM CORP FLDM 0001680808 Linthwaite Stephen Christopher C/O FLUIDIGM CORPORATION 2 TOWER PLACE, STE 2000 SOUTH SAN FRANCISCO CA 94080 0 1 0 0 President & CEO Common Stock 2021-02-20 4 M 0 3167 0 A 150594 D Common Stock 2021-02-20 4 M 0 7813 0 A 158407 D Common Stock 2021-02-20 4 M 0 6882 0 A 165289 D Common Stock 2021-02-20 4 M 0 30888 0 A 196177 D Common Stock 2021-02-20 4 A 0 64609 0 A 260786 D Common Stock 2021-02-20 4 F 0 57705 6.12 D 203081 D Restricted Stock Units 2021-02-20 4 M 0 3167 0 D Common Stock 3167.0 0 D Restricted Stock Units 2021-02-20 4 M 0 7813 0 D Common Stock 7813.0 39065 D Restricted Stock Units 2021-02-20 4 M 0 6882 0 D Common Stock 6882.0 55056 D Restricted Stock Units 2021-02-20 4 M 0 30888 0 D Common Stock 30888.0 92667 D Includes 2,080 shares purchased on November 30, 2020 under the Company's 2017 Employee Stock Purchase Plan. Represents shares acquired as a result of the certification of the performance condition for performance-based Restricted Stock Units granted on March 19, 2018. Each Restricted Stock Unit represents the contingent right to receive one share of FLDM common stock. On February 13, 2017, the Reporting Person was granted 76,000 Restricted Stock Units vesting as to 1/12th of the total number of shares on May 20, 2017, and as to 1/16th of the total number of shares each quarter thereafter. On June 11, 2018, the Reporting Person was granted 125,000 Restricted Stock Units vesting as to 1/16th of the total number of shares on August 20, 2018, and as to 1/16th of the total number of shares each quarter thereafter. On February 19, 2019, the Reporting Person was granted 110,112 Restricted Stock Units vesting as to 1/4th of the total number of shares on February 20, 2020, and as to 1/16th of the total number of shares each quarter thereafter. On March 10, 2020, the Reporting Person was granted 123,555 Restricted Stock Units vesting as to 1/4th of the total number of shares on February 20, 2021, and as to 1/16th of the total number of shares each quarter thereafter. /s/ Stephen Christopher Linthwaite by Nicholas Khadder, Attorney-in-Fact 2021-02-23